Delivery Order SPE2DR25D2005-SPE2DR26FE6G3
- Not listed
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,467.14 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for Yuvafem 10 mcg vaginal inserts (18 count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a $30,704.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count) on October 22, 2025, with completion scheduled for October 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,297.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (8-count package) on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed-price delivery order for pharmaceutical supply. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,616.29 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count package) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,543.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,115.12 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. This delivery order...
- The Defense Logistics Agency awarded a $1,967.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 8, 2025, with completion targeted for September 9, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6G3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,644.34 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Yuvafem, a hormone replacement therapy product, exemplifies the company's role in supplying specialized pharmaceuticals to support Defense Health Agency and other federal healthcare systems through its comprehensive IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/5/25 |